Clinical Review

Female genital cutting: Caring for patients through the lens of health care equity

Author and Disclosure Information

Culturally competent and sensitive ObGyn care for women who have undergone female genital cutting is paramount to reducing health care inequities for these patients


 

References

Female genital cutting (FGC), also known as female circumcision or female genital mutilation, is defined by the World Health Organization (WHO) as “the partial or total removal of the external female genitalia, or other injury to the female genital organs for non-medical reasons.”1 It is a culturally determined practice that is mainly concentrated in certain parts of Africa, the Middle East, and Asia and now is observed worldwide among migrants from those areas.1 Approximately 200 million women and girls alive today have undergone FGC in 31 countries, although encouragingly the practice’s prevalence seems to be declining, especially among younger women.2

Too often, FGC goes unrecognized in women who present for medical care, even in cases where a genitourinary exam is performed and documented.3,4 As a result, patients face delays in diagnosis and management of associated complications and symptoms. Female genital cutting is usually excluded from medical school or residency training curricula,5 and physicians often lack familiarity with the necessary clinical or surgical management of patients who have had the procedure.6 It is crucial, however, that ObGyns feel comfortable recognizing FGC and clinically caring for pregnant and nonpregnant patients who have undergone the procedure. The obstetric-gynecologic setting should be the clinical space in which FGC is correctly diagnosed and from where patients with complications can be referred for appropriate care.

FGC: Through the lens of inequity

Providing culturally competent and sensitive care to women who have undergone FGC is paramount to reducing health care inequities for these patients. Beyond the medical recommendations we review below, we suggest the following considerations when approaching care for these patients.

Acknowledge our biases. It is paramount for us, as providers, to acknowledge our own biases and how these might affect our relationship with the patient and how our care is received. This starts with our language and terminology: The term female genital mutilation can be judgmental or offensive to our patients, many of whom do not consider themselves to have been mutilated. This is why we prefer to use the term female genital cutting, or whichever word the patient uses, so as not to alienate a patient who might already face many other barriers and microaggressions in seeking health care.

Control our responses. Another way we must check our bias is by controlling our reactions during history taking or examining patients who have undergone FGC. Understandably, providers might be shocked to hear patients recount their childhood experiences of FGC or by examining an infibulated scar, but patients report noticing and experiencing hurt, distress, and shame when providers display judgment, horror, or disgust.7 Patients have reported that they are acutely aware that they might be viewed as “backward” and “primitive” in US health care settings.8 These kinds of feelings and experiences can further exacerbate patients’ distrust and avoidance of the health care system altogether. Therefore, providers should acknowledge their own biases regarding the issue as well as those of their staff and work to mitigate them.

Avoid stigmatization. While FGC can have long-term effects (discussed below), it is important to remember that many women who have undergone FGC do not experience symptoms that are bothersome or feel that FGC is central to their lives or lived experiences. While we must be thorough in our history taking to explore possible urinary, gynecologic, and sexual symptoms of concern and bother to the patient, we must avoid stigmatizing our patients by assuming that all who have undergone FGC are “sexually disabled,” which may lead a provider to recommend medically unindicated intervention, such as clitoral reconstruction.9

Continue to: Classifying FGC types...

Pages

Recommended Reading

Obesity pegged as source of marked increased risk of diabetes in PCOS
MDedge ObGyn
The pandemic is making periods unbearable for some women
MDedge ObGyn
Antimicrobial, pH-modulating gel shows promise in preventing common STIs
MDedge ObGyn
How physicians can provide better care to transgender patients
MDedge ObGyn
Optimize your treatment of endometriosis by using an FDA-approved hormonal medication
MDedge ObGyn
Can a once-daily oral formulation treat symptoms of uterine fibroids without causing hot flashes or bone loss?
MDedge ObGyn
Patient-centered contraceptive care for medically complex patients
MDedge ObGyn
FDA lifts in-person dispensing requirement for mifepristone
MDedge ObGyn
HHS proposes overturning Title X ‘gag’ rule
MDedge ObGyn
Do ObGyns plan on getting a 9vHPV vaccine?
MDedge ObGyn